Your browser doesn't support javascript.
loading
Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level.
Zhao, Zhangxiang; Jin, Tongzhu; Chen, Bo; Dong, Qi; Liu, Mingyue; Guo, Jiayu; Song, Xiaoying; Li, Yawei; Chen, Tingting; Han, Huiming; Liang, Haihai; Gu, Yunyan.
Affiliation
  • Zhao Z; The Sino-Russian Medical Research Center of Jinan University, The Institute of Chronic Disease of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Jin T; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Chen B; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Dong Q; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Liu M; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Guo J; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Song X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Li Y; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Chen T; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Han H; Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Liang H; The Sino-Russian Medical Research Center of Jinan University, The Institute of Chronic Disease of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Gu Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Cell Cycle ; 22(20): 2229-2244, 2023 10.
Article in En | MEDLINE | ID: mdl-37974462
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Cell Cycle Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Cell Cycle Year: 2023 Type: Article Affiliation country: China